Primary Paclitaxel Plus Gemcitabine in Patients With Stage II and III Breast Cancer
Clinical trial NCT00532285 · TERMINATED
Trial details
- NCT number
- NCT00532285
- Sponsor
- National Cancer Center, Korea
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-09-01
- Primary completion
- 2006-04-01
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.